Sitemap

Categories

• Press releases
• Featured Research
• Inmedix Publications
• Enrolling Studies

All Press Release

• Inmedix to Host First Annual Inmedix Golf Tournament
• Inmedix meets with NICE and NOCRI, establishes subsidiary, Inmedix UK, Ltd.
• Inmedix CEO to Co-Chair Study Group Highlighting Autonomic Nervous System (ANS) Effect on Autoimmune Disease Treatment Success at ACR/ARHP Annual Meeting 2016
• Inmedix immuno-autonomics strategies projected to save payers billions
• Inmedix hosts 2nd annual charity golf tournament to support kids with arthritis.
• Inmedix welcomes Leonard H. Calabrese, DO, Professor of Medicine, Cleveland Clinic, to its Scientific Advisory Board.
• Inmedix CEO to co-chair immuno-autonomics study group at 2018 annual meeting of the American College of Rheumatology.
• Inmedix immuno-autonomics video animation released at 2018 annual ACR meeting
• Inmedix makes the cut at 2019 Medtech Innovator Competition
• Inmedix introduces immuno-autonomics to the 2019 Life Science Innovation Northwest Conference
• Inmedix heads to the Golf Club at Newcastle to support kids with arthritis
• Inmedix raises nearly $16,000 for Seattle Children's Hospital
• Inmedix CEO Co-Chairs Immuno-autonomics Study Group at the 2019 Annual Meeting of the American College of Rheumatology
• Inmedix CEO to Co-chair Immuno-autonomics Study Group at the 2019 Annual Meeting of the American College of Rheumatology
• Inmedix to present at the November, 2019 Keiretsu Forum Bay Area Investor Capital Expo
• Inmedix is all in at the 2020 USA Science & Engineering Festival in Washington, DC.
• Inmedix welcomes Bernie Tobin, former President of Crescendo Bioscience, to its Board of Directors
• Fourth Inmedix charity golf tournament support kids with arthritis
• Norman B. Gaylis, MD, FACP, MACR joins Inmedix Scientific Advisory Board
• Inmedix recognized as a 'Most Valued Company' at virtual Keiretsu Forum Investor Capital Expo
• Inmedix presents at 2021 LSINW conference
• Inmedix raises $31,470 to support kids with arthritis at Seattle Children’s Hospital
• Inmedix again a Keiretsu Expo Most Valued Company in 2021
• One more time! Again, Inmedix is voted “A most Valued Company” at another 2021 Keiretsu Forum Investor Expo
• Inmedix selected as a 2022 FiReStarter Company by Future in Review
• Inmedix supports a leading UK charity for rheumatoid arthritis, NRAS, to develop ‘Stress Matters’ resources
• Inmedix returns to the Life Science Innovation Northwest Conference in 2022
• Seattle MedTech Inmedix announces its 6th Annual Charity Golf Tournament to Support Kids with Arthritis
• Inmedix supports the 2022 OPAL Family Office & Private Wealth Management Forum in Newport, RI as a Platinum Sponsor.
• Inmedix announces pilot collaboration with the Spaulding Integrative Rehabilitation Laboratory.
• Inmedix® raises another $19,405 to support kids with arthritis at Seattle Children’s Hospital
• Inmedix welcomes Leroy Hood MD PhD to its Board of Directors
• Inmedix to Present at the 2023 Spring Keiretsu Forum Investor Capital Expo.
• Inmedix welcomes Kevin J. Tracey, MD, to its Board of Directors
• Inmedix welcomes Lee S. Simon, MD, to its Regulatory Advisory Team
• Inmedix raises another $35,285 to support kids with arthritis at Seattle Children’s Hospital
• Inmedix appoints Nathan Smith as CFO as it approaches US commercialization
• Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.
• Inmedix completes $4M bridge convertible note round with angel investors to develop and commercialize medical-grade HRV
• Inmedix unrestricted educational grant supports UK ‘Stress Matters’ patient advocacy project.
• Inmedix raises another $38,765 for kids with arthritis at Seattle Children's
• FDA clears Inmedix CloudHRV System diagnostic for US commercialization
• Inmedix CEO Andrew J. Holman, MD, lectures at the 2025 Precision Medicine World Conference
• Inmedix® announces the US launch of its FDA-cleared CloudHRV™ System at the 2025 Rheumatology Winter Clinical Symposium.
• Inmedix announces the US launch of its FDA-cleared CloudHRV™ System.
• Inmedix Recognized as the #1 ‘Most Valued Company’ at the Spring 2025 PNW & Rockies Keiretsu Forum Investor Capital Expo
• Inmedix® introduces the new CloudHRV™ clinical diagnostic to the 2025 Life Science Innovation Northwest Conference

All Page

• Styles Guide
• Investor Relations
• Contact Us
• Presentations
• About
• Inmedix UK Ltd
• Careers
• Privacy
• Terms & Conditions

All CloudHRV Page

• Privacy Policy
• Terms of Service
• Coordinated Disclosure Process
• Security Bulletins
• Acknowledgements
• CloudHRV Product Description

Categories

• Our Approach
• Therapeutic Interests
• Our Products
• AI Services

All Service

• Fibromyalgia
• Rheumatoid Arthritis (RA)
• Multiple Sclerosis
• LB Project

All Profiles

• Andrew J. Holman MD
• T.V. Sciarrillo
• Steven Daly MBA
• Unnamed CFO
• Stuart Hwang PhD
• Glynis Thakur
• Daniel Austen
• Michael E. Weinblatt MD
• James O’Dell MD
• Edward C Keystone MD
• Vibeke Strand MD
• Daniel E. Furst MD
• Robert E. Ettlinger MD
• Ernest Choy MD, FRCP
• Peter Taylor MD, PhD, FRCP
• Leonard Calabrese DO
• Jolene Anderson
• StarFish Medical
• Larry Bock
• Bernie Tobin
• Norman B. Gaylis MD
• R. Doug Cooper
• Brianna McDonald
• Dennis Takasugi
• Leslie Bottorff
• Leroy Hood MD PhD
• Alex Bangs
• Kevin J. Tracey MD
• Lee S. Simon, MD, FACP, MACR
• Nathan A. Smith
• Lucy Lu
• Brian Doll
• Ryan Sullivan, PhD
• Nicolaus Heinen
• Naz Rokni